Metropolitan Life Insurance Company (MetLife)’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-1,847
| Closed | -$71.7K | – | 479 |
|
2024
Q1 | $71.7K | Sell |
1,847
-359
| -16% | -$13.9K | ﹤0.01% | 1225 |
|
2023
Q4 | $67.9K | Hold |
2,206
| – | – | ﹤0.01% | 1285 |
|
2023
Q3 | $49.3K | Buy |
2,206
+294
| +15% | +$6.57K | ﹤0.01% | 1413 |
|
2023
Q2 | $41.1K | Buy |
+1,912
| New | +$41.1K | ﹤0.01% | 1542 |
|
2023
Q1 | – | Sell |
-2,229
| Closed | -$51.7K | – | 2343 |
|
2022
Q4 | $51.7K | Hold |
2,229
| – | – | ﹤0.01% | 1450 |
|
2022
Q3 | $35.7K | Hold |
2,229
| – | – | ﹤0.01% | 1690 |
|
2022
Q2 | $39.5K | Hold |
2,229
| – | – | ﹤0.01% | 1647 |
|
2022
Q1 | $45.4K | Sell |
2,229
-9,431
| -81% | -$192K | ﹤0.01% | 1652 |
|
2021
Q4 | $218K | Hold |
11,660
| – | – | ﹤0.01% | 1975 |
|
2021
Q3 | $230K | Buy |
+11,660
| New | +$230K | ﹤0.01% | 1961 |
|
2021
Q2 | – | Sell |
-10,825
| Closed | -$257K | – | 2744 |
|
2021
Q1 | $257K | Hold |
10,825
| – | – | ﹤0.01% | 1852 |
|
2020
Q4 | $217K | Hold |
10,825
| – | – | ﹤0.01% | 1889 |
|
2020
Q3 | $225K | Hold |
10,825
| – | – | ﹤0.01% | 1702 |
|
2020
Q2 | $189K | Sell |
10,825
-299
| -3% | -$5.23K | ﹤0.01% | 1835 |
|
2020
Q1 | $182K | Hold |
11,124
| – | – | ﹤0.01% | 1647 |
|
2019
Q4 | $229K | Hold |
11,124
| – | – | ﹤0.01% | 1818 |
|
2019
Q3 | $128K | Hold |
11,124
| – | – | ﹤0.01% | 2165 |
|
2019
Q2 | $146K | Hold |
11,124
| – | – | ﹤0.01% | 2104 |
|
2019
Q1 | $168K | Hold |
11,124
| – | – | ﹤0.01% | 2023 |
|
2018
Q4 | $191K | Hold |
11,124
| – | – | ﹤0.01% | 1852 |
|
2018
Q3 | $164K | Buy |
+11,124
| New | +$164K | ﹤0.01% | 2145 |
|